(Press-News.org) JACKSONVILLE, Fla. -- A drug recently approved for use in multiple myeloma is now being tested for its ability to fight central nervous system (CNS) lymphoma, a deadly cancer of the immune system that can affect the brain, spinal cord and fluid, and eyes. The clinical trial, now open at the three campuses of Mayo Clinic -- in Florida, Minnesota and Arizona -- follows successful testing of the drug, pomalidomide, in mouse models of CNS lymphoma. Details of the preclinical testing are available in the science journal PLOS ONE.
Approximately 5,000 patients are diagnosed with the disease every year in the United States.
"We believe pomalidomide could be beneficial in patients with this cancer because it does two things that most anti-cancer drugs do not do," says Han Tun, M.D., an oncologist at Mayo Clinic in Florida. "The drug has excellent brain penetration, which is a requirement in treatment of brain tumors. The other interesting thing is that it is not only active directly against lymphoma cells but also alters the tumor microenvironment."
Dr. Tun is the senior investigator of the PLOS ONE study and the principal investigator for the clinical trial, which is accruing patients.
"Our preclinical study suggests pomalidomide is very promising. Treatment with pomalidomide in mouse models for CNS lymphoma significantly improved the survival and suppressed the tumor growth," he says. "The phase I clinical trial was developed based on these preclinical results."
Pomalidomide belongs to a class of drugs called immunomodulatory agents. Thalidomide was the first drug in this class and was approved in 2006 for treatment of multiple myeloma, a bone marrow cancer. Pomalidomide was approved for use in multiple myeloma in February.
###
Study co-authors include five researchers from Celgene, the manufacturer of pomalidomide. Other co-authors are Zhimin Li, Ph.D, Yushi Qiu, M.D., Peng Huang, Ph.D, David Personett, Brandy Edenfield, and John Copland, Ph.D., all from Mayo Clinic Florida.
Dr. Tun received a grant from Celgene to support this research.
About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit http://www.mayoclinic.com and http://www.mayoclinic.org/news.
Journalists can become a member of the Mayo Clinic News Network for the latest health, science and research news and access to video, audio, text and graphic elements that can be downloaded or embedded.
Mayo Clinic: Preclinical tests may lead to new approach to treat CNS lymphoma
2013-08-12
ELSE PRESS RELEASES FROM THIS DATE:
Communicating nightingales: Older males trill better
2013-08-12
Older male nightingales perform faster and more demanding trills than their younger rivals. These findings were published by researchers at the University of Basel and the Netherlands Institute of Ecology in the online edition of Journal of Avian Biology. With up to 100 trill elements a second, nightingales belong to the fastest singers.
Nightingales are famous for their large song repertoire: Each male can perform around 200 different song types. Facing this great variety, how can a female listener assess correctly if the male counterpart is a suitable mating partner? ...
Competition changes how people view strangers online
2013-08-12
COLUMBUS, Ohio -- An anonymous stranger you encounter on websites like Yelp or Amazon may seem to be just like you, and a potential friend. But a stranger on a site like eBay is a whole different story.
A new study finds that on websites where people compete against each other, assumptions about strangers change.
Previous research has shown that people have a bias toward thinking that strangers they encounter online are probably just like them.
But when they are competitors, strangers are seen as different, and not sharing your traits and values -- and that changes ...
New materials for bio-based hydrogen synthesis
2013-08-12
Researchers at the Ruhr-Universität Bochum (RUB) have discovered an efficient process for hydrogen biocatalysis. They developed semi-synthetic hydrogenases, hydrogen-generating enzymes, by adding the protein's biological precursor to a chemically synthesized inactive iron complex. From these two components, the biological catalyst formed spontaneously in a test tube. "Extracting hydrogenases from living cells is highly difficult," says Prof Dr Thomas Happe, head of the work group Photobiotechnology at the RUB. "Therefore, their industrial application has always been a long ...
Simulating flow from volcanoes and oil spills
2013-08-12
WASHINGTON D.C. August 12, 2013 -- Some time around 37,000 BCE a massive volcano erupted in the Campanian region of Italy, blanketing much of Europe with ash, stunting plant growth and possibly dooming the Neanderthals. While our prehistoric relatives had no way to know the ash cloud was coming, a recent study provides a new tool that may have predicted what path volcanic debris would take.
"This paper provides a model for the pattern of the ash cloud if the wind is blowing past an eruption of a given size," said Peter Baines, a scientist at the University of Melbourne ...
Scientists develop method that ensures safe research on deadly flu viruses
2013-08-12
A new strategy that dismantles a viral genome in human lung cells will ensure safe research on deadly strains of influenza, say researchers from the Icahn School of Medicine at Mount Sinai.
Details of their "molecular biocontainment" approach, designed to prevent effective transmission of these viruses to humans, are published in Nature Biotechnology.
The strategy they developed and tested will enable healthy molecules in human lung cells to latch on to these viruses and cut the bugs up before they have a chance to infect the human host.
Findings from the study, ...
Expert: Taxation of retirement income in need of reform
2013-08-12
CHAMPAIGN, Ill. — Although planning for a comfortable retirement is a mainstay of public discussion, far less attention has been paid to the tax consequences of generating retirement income, says a University of Illinois expert on taxation and retirement benefits.
According to law professor Richard L. Kaplan, the income tax consequences for retirees are varied, outdated or often outright inappropriate.
"Legal and financial analyses abound regarding the various means of saving for retirement and the tax advantages that each option presents, but very few people consider ...
New insights into neuroblastoma tumor suppressor may provide clues for improved treatment
2013-08-12
August 12, 2013, New York, NY – Loss of a gene required for stem cells in the brain to turn into neurons may underlie the most severe forms of neuroblastoma, a deadly childhood cancer of the nervous system, according to a Ludwig Cancer Research study. Published in Developmental Cell today, the findings also provide clues about how to improve the treatment of this often-incurable tumor.
Neuroblastoma can appear in nervous tissue in the abdomen, chest and spine, among other regions of the body, and can spawn body-wracking metastasis. The most severe tumors respond poorly ...
Why early pregnancy conferes breast cancer protection
2013-08-12
An international scientific collaborative led by the Harvard Stem Cell Institute's Kornelia Polyak, MD, PhD, has discovered why women who give birth in their early twenties are less likely to eventually develop breast cancer than women who don't, triggering a search for a way to confer this protective state on all women.
The researchers now are in the process of testing p27, a mammary gland progenitor marker, in the tissue of thousands of women collected over a 20-year period—women whose histories have been followed extremely closely—to see if it is an accurate breast ...
Few doctors have adequate training to effectively treat chronic pain patients
2013-08-12
DETROIT – Pain is the most common reason a patient sees a physician but few physicians have received adequate training to help their patients, according to a Henry Ford Hospital article published in the Journal of American Osteopathic Association.
An estimated 100 million people in the United States are living with chronic pain, which accounts for up to $635 billion annually in health care costs and lost productivity. A 2011 study found that for every medical specialist, there are more than 28,500 patients with chronic pain.
Consequently, pain management typically ...
Child obesity interventions -- is change in BMI a good measure of success?
2013-08-12
New Rochelle, NY -- Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI. Focusing on a single factor like the degree of BMI change is restrictive and can overlook other important outcomes, according to an article published in Childhood Obesity, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. ...